Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ExosensCHIX:EXENSP 42 Equity-to-Asset is 0.51 as of Dec. 2025, which is 42% above its 10-year median of 0.36. GuruFocus rates CHIX:EXENSP with a GF Score™ of 42/100. The stock has 7 warning signs investors should review. Among 3,073 Industrial Products companies, Exosens ranks worse than 59.1% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Exosens's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €445.6 Mil. Exosens's Total Assets for the quarter that ended in Dec. 2025 was €878.9 Mil.
Therefore, Exosens's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.51.
The historical rank and industry rank for Exosens's Equity-to-Asset or its related term are showing as below:
CHIX:EXENSp'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.16 Med: 0.36 Max: 0.51
Current: 0.51
During the past 6 years, the highest Equity to Asset Ratio of Exosens was 0.51. The lowest was 0.16. And the median was 0.36.
CHIX:EXENSp's Equity-to-Asset is ranked worse than 59.1% of 3073
companies
in the Industrial Products industry
Industry Median: 0.57
vs CHIX:EXENSp: 0.51
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Exosens Equity-to-Asset Related Terms
Exosens Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Exosens's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:EXENSP vs VRT, BE, HUBB: Equity-to-Asset Comparison
For the Electrical Equipment & Parts subindustry, Exosens's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exosens Equity-to-Asset vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Exosens's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Exosens's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Exosens's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Exosens (CHIX:EXENSP) has a Equity-to-Asset of 0.51 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Exosens and its competitors. This is 42% above median its historical median of 0.36. Over the past decade, Exosens' Equity-to-Asset has ranged from 0.16 to 0.51. According to the industry distribution chart, Exosens ranks #1816 out of 3073 companies in the Industrial Products industry, placing it in the top 59.1%.
Is Exosens' Equity-to-Asset too high?
Exosens' current Equity-to-Asset of 0.51 is 42% above median its 10-year median of 0.36. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 0.51. The Industrial Products industry median Equity-to-Asset is 0.57. Exosens' value of 0.51 is 10.5% below this industry median. Based on the distribution chart, Exosens ranks #1816 out of 3073 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Exosens has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' Equity-to-Asset compare to VRT and BE?
According to the Industrial Products industry distribution chart, Exosens ranks #1816 out of 3073 companies for Equity-to-Asset. This places Exosens in the lower half of its industry. The industry median Equity-to-Asset is 0.57. Exosens' value of 0.51 is 10.5% below this benchmark. Historically, Exosens' own Equity-to-Asset has ranged from 0.16 to 0.51 over the past decade. While the company's 10-year median is 0.36 vs. the industry median of 0.57, Exosens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for an Industrial Products company?
The median Equity-to-Asset among Industrial Products companies is 0.57, based on 3,073 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Exosens's current Equity-to-Asset of 0.51 is 10.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Exosens and its competitors. For the Industrial Products industry, the median Equity-to-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exosens's current Equity-to-Asset is 0.51, which is 42% above median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (CHIX:EXENSP) has a current Equity-to-Asset of 0.51. The current Equity-to-Asset is 0.51, which is 42% above median its 10-year median of 0.36 and 10.5% below the Industrial Products industry median of 0.57. Exosens' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Exosens (CHIX:EXENSP), the current Equity-to-Asset is 0.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
42GF Score
Get the complete analysis for CHIX:EXENSP
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:EXENSP has been successfully added to your 
